Mortality in systemic sclerosis - A single centre study from the UK

Clinical Rheumatology

Volumn 32, Issue 10, 2013, Pages 1533-1539

  Strickland, Gemma ^a   Pauling, John ^a   Cavill, Charlotte ^b   Shaddick, Gavin ^c   McHugh, Neil ^a,b,d  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^b Bath Institute for Rheumatic Diseases   (United Kingdom)

^c University of Bath   (United Kingdom)

^d University of Bath   (United Kingdom)

Author keywords

Cause of death; England; Mortality; Survival; Systemic sclerosis; Wales

Indexed keywords

DNA DIRECTED RNA POLYMERASE III;

ADULT; ARTICLE; BIRTH; CAUSE OF DEATH; CONFIDENCE INTERVAL; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DATA BASE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INTERSTITIAL LUNG DISEASE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGISTER; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; SEX DIFFERENCE; STANDARDIZED MORTALITY RATIO; SURVIVAL; SYSTEMIC SCLEROSIS; UNITED KINGDOM;

ADULT; AGE FACTORS; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; REGISTRIES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84885309893     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2289-0     Document Type: Article

References (34)

1. Black CM, Matucci-Cerinic M, Guillevin L (2009) Progress in systemic sclerosis: a 10-year perspective. Rheumatology (Oxford) 48(Suppl 3):iii1-iii2
2. Elhai M, Meune C, Avouac J, Kahan A, Allanore Y (2012) Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 51(6):1017-1026
3. Chung L, Krishnan E, Chakravarty EF (2007) Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample. Rheumatology (Oxford) 46(12):1808-1813
4. Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 66(7):940-944
5. Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69(10):1809-1815
6. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23(5):581-590
7. LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28(7):1573-1576
8. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202-205
9. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, et al. (2009) Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54(1 Suppl):S55-S66
10. R Development Core Team (2011) R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; URL: http://www.R-project.org. Accessed 1 Apr 2012
11. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48(8):2246-2255
12. Walker UA, Tyndall A, Czirjak L, Denton CP, Farge-Bancel D, Kowal-Bielecka O, et al. (2009) Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database. Ann Rheum Dis 68(6):856-862
13. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, et al. (2005) Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 118(1):2-10
14. Hissaria P, Lester S, Hakendorf P, Woodman R, Patterson K, Hill C, et al. (2011) Survival in scleroderma: results from the population-based South Australian Register. Int Med J 41(5):381-390
15. Vettori S, Cuomo G, Abignano G, Iudici M, Valentini G (2010) Survival and death causes in 251 systemic sclerosis patients from a single Italian center. Reumatismo 62(3):202-209
16. Joven BE, Almodovar R, Carmona L, Carreira PE (2010) Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital. Semin Arthritis Rheum 39(4):285-293
17. Bryan C, Howard Y, Brennan P, Black C, Silman A (1996) Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol 35(11):1122-1126
18. Simeon CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, et al. (2003) Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology (Oxford) 42(1):71-75
19. Abu-Shakra M, Lee P (1995) Mortality in systemic sclerosis: a comparison with the general population. J Rheumatol 22(11):2100-2102
20. Arias-Nunez MC, Llorca J, Vazquez-Rodriguez TR, Gomez-Acebo I, Miranda-Filloy JA, Martin J, et al. (2008) Systemic sclerosis in north-western Spain: a 19-year epidemiologic study. Medicine (Baltimore) 87(5):272-280
21. Geirsson AJ, Wollheim FA, Akesson A (2001) Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale. Ann Rheum Dis 60(12):1117-1122
22. Hesselstrand R, Scheja A, Akesson A (1998) Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 57(11):682-686
23. Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, et al. (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81(2):154-167
24. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81(2):139-153
25. Hashimoto A, Tejima S, Tono T, Suzuki M, Tanaka S, Matsui T, et al. (2011) Predictors of survival and causes of death in Japanese patients with systemic sclerosis. J Rheumatol 38(9):1931-1939
26. Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF (2011) Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong. China Arthritis Rheum 63(5):1182-1189
27. Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37(7):750-755
28. Derk CT, Rasheed M, Artlett CM, Jimenez SA (2006) A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 33(6):1113-1116
29. Hill CL, Nguyen AM, Roder D, Roberts-Thomson P (2003) Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 62(8):728-731
30. Steen VD, Medsger TA Jr (2000) Long-term outcomes of scleroderma renal crisis. Ann Intern Med 133(8):600-603
31. Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35(1):35-42
32. Penn H, Howie AJ, Kingdon EJ, Bunn CC, Stratton RJ, Black CM, et al. (2007) Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 100(8):485-494
33. Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P (2001) Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 28(11):2454-2459
34. Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, et al. (2007) Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum 56(8):2740-2746